Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NTSR1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | TRIP6 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | TBC1D25 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | RNF43 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | PTPN22 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | SUSD3 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | RP11-87C12.2 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | TSPYL2 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | CD79B | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | SCLY | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |